Key transcriptional regulators, such as c-Myc, p53, and HIF-1, further reinforce this metabolic bias by upregulating genes that encode glucose transporters and glycolytic enzymes, thereby intensifying the glycolytic phenotype characteristic of CRC cells (182). This evidence concerns the gene HK1 and colorectal carcinoma.